Cresset Asset Management, LLC Evelo Biosciences, Inc. Transaction History

Cresset Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.86 - $3.01 $3,039 - $4,918	-1,634 Reduced 8.17%	18,366 $38,000
Q2 2022 Aug 15, 2022	SELL	$1.46 - $3.55 $14,600 - $35,500	-10,000 Reduced 33.33%	20,000 $42,000
Q1 2022 May 16, 2022	BUY	$2.66 - $6.63 $53,200 - $132,600	20,000 Added 200.0%	30,000 $102,000
Q2 2021 Aug 10, 2021	BUY	$9.43 - $16.6 $94,300 - $166,000	10,000 New	10,000 $137,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.